Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in pati... od O'Brien, M, Cronin, A, Fearn, P, Smith, B, Stasi, J, Guillonneau, B, Scardino, P, Eastham, J, Vickers, A, Lilja, H

Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively. od O'Brien, M, Cronin, A, Fearn, P, Savage, C, Smith, B, Stasi, J, Scardino, P, Fisher, G, Cuzick, J, Møller, H, Oliver, RT, Berney, D, Foster, C, Eastham, J, Vickers, A, Lilja, H